IOL Chemicals and Pharmaceuticals Ltd, a leading manufacturer of pharmaceutical APIs and speciality chemicals, announced its financial results for the first quarter ended June 30, 2023.

The total income for Q1 FY24 stood at INR 570 crore at the same level of INR 570 crore YoY. EBITDA for Q1 FY24 was INR 80 crore as compared to INR 61 crore YoY and net profit for Q1 FY24 stood at INR 46 crore as compared to INR 35 crore YoY

Commenting on the performance, Vikas Gupta, Joint Managing Director, said “We are pleased to report sustainable performance during the 1^st quarter of FY24, tackling present challenges while positioning ourselves for forthcoming opportunities. We are hopeful for increased presence in regulatory market as the Company got CEP for paracetamol. Additionally, with the commencement of Acetic Anhydride plant, focus on improved efficiencies, product mix and timely execution we are hopeful to generate strong cash flow”.